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Protein energy waste is a common complication in pa-
tients undergoing dialysis, and it results from loss of 
proteins and a disturbed balance between protein 
breakdown and protein synthesis [1, 2]. First of all, 
there is an inappropriate removal of proteins during 
dialysis, and haemodialysis (HD) has been proposed to 
be catabolic per se [3]. The underlying reasons for the 
disturbance between protein breakdown and synthesis 
also include insulin resistance [4-6], reduced levels of 
and resistance to anabolic hormones [7, 8], acidosis  
[9, 10], chronic inflammation [11], physical inactivity 
[12] and insufficient total energy and protein ingestion 
[13]. Thus, protein energy waste in patients undergo-
ing dialysis is a result of several factors and associated 
with an elevated risk of mortality [14]. Muscle atrophy 
prevention in patients undergoing dialysis is therefore 
an important target in clinical practice [15].
Strength training with high loads is recognised as 
the training modality with the most pronounced effect 
on muscle growth [16, 17]. Strength training involves 
an increase in protein synthesis but also an increase in 
protein breakdown. However, in general, the protein 
synthesis exceeds the protein breakdown, leading to a 
net hypertrophic effect in the muscle. The question re-
mains if protein energy waste counteracts the potential 
protein accretion leading to muscle hypertrophy with 
strength training in patients undergoing dialysis.
Recent reviews have evaluated effects of general  
exercise training in patients undergoing dialysis in 
studies with different training modalities, intensities 
and research designs [18-22]. The objective of this sys-
tematic review was to investigate the effects of strength 
training on muscle mass, muscle strength, physical 
function and quality of life (QoL) in patients undergo-
ing dialysis. Only randomised controlled trials (RCTs) 
with a strength training intervention were included.
METHODS
This study was conducted in accordance with the 
PRISMA statement and the protocol was registered 
with PROSPERO (no. CRD42016053338).
Published RCTs assessing the effects of an interven-
tion with strength training versus a control group with-
out exercise training were included. Trials with more 
than one intervention and thereby more than two study 
arms were included if it was possible to compare a 
strength training group with a control group. The par-
ticipants had to be ≥ 18 years of age and be undergo-
ing chronic dialysis (HD or peritoneal dialysis) ≥ 1 
month. Exercise training programmes with or without 
a supplementary nutritional or pharmaceutical treat-
ment to enhance the muscle mass or size were in-
cluded. The training programme needed to be struc-
tured, described in a manner that made it re-producible 
and include strength training as defined by the authors.
The search for RCTs was performed with the assist-
ance of a trained librarian. We searched The Cochrane 
Library (CENTRAL), MEDLINE (PubMed), Embase, 
CINAHL and PEDro. Manuscript languages were re-
stricted to English, Danish, Swedish and Norwegian. 
An example of a search in MEDLINE: (Dialysis OR 
Hemodialysis OR Haemodialysis OR Peritoneal dialy-
ABSTRACT
INTRODUCTION: Chronic kidney disease is associated with 
several negative factors that may counteract the potential 
effects of strength training. The purpose of this systematic 
review was to explore the effects of strength training on 
muscle mass, muscle strength, physical function and 
quality of life in patients undergoing dialysis.
METHODS: A literature search was conducted in The 
Cochrane Library, MEDLINE, Embase, CINAHL and PEDro.  
Eight randomised, controlled trials of patients undergoing 
haemodialysis (n = 290) were included.
RESULTS: There were inconsistencies in the results on the 
effects of strength training on muscle mass. Muscle 
strength was improved in six of eight tests. Objectively 
tested physical function remained unchanged. Pooled data 
for self-rated physical health and physical function from 
Short Form 36 were improved with strength training (mean 
(95% confidence interval) 10.05 (2.95-17.14), p = 0.006, and 
9.38 (0.79-17.97), p = 0.03, respectively).
CONCLUSIONS: The results suggest that it may be difficult 
to increase muscle mass with strength training in patients 
who are undergoing haemodialysis. Muscle growth may be 
impaired as a result of several catabolic conditions. Strength 
training was associated with important clinical outcomes 
including increased muscle strength and improved self-
rated physical health and function.
2sis) AND (Exercise OR Training). Reference lists were 
hand searched for other potentially relevant RCTs. Two 
authors independently screened the titles and abstracts 
to identify potential RCTs to be included, reviewed the 
full-text publications of the potentially included RCTs 
and extracted and collected data. Disagreements in the 
assessments were resolved through discussions be-
tween all authors.
The primary outcomes were tests of muscle mass or 
size including whole muscle mass (e.g. assessed using 
dual-energy X-ray absorptiometry (DXA), CT or mag-
netic resonance imaging (MRI) methods), muscle cross 
sectional area or single muscle fibre cross sectional 
area (e.g. by computer image analysis). The secondary 
outcomes were tests of muscle strength (e.g. using dy-
namometers or one repetition maximum (RM) tests), 
objectively tested physical function (e.g. the chair-
stand test), QoL (e.g. Short Form 36 (SF36) question-
naire) and adverse effects.
Risk of bias in the included RCTs was assessed using 
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TABLE 1
The characteristics of the included studies. All participants were undergoing haemodialysis.
Participants
Reference
included/  
follow-up, n
age, yrs, mean ± SD  
gender, m/f, n Intervention Outcome Comment
Inter HD
Dong et al, 2011, US [41] 32/22 Int: 46.5 ± 12.1, con: 
40.2 ± 13.5a
Int: 9/6, con: 12/5
Leg press 3 × 12 reps, up to 
82% of 1RM, 3 × weekly for  
6 mo.s
LBM: DXA
Muscle strength: 1RM
Exercise prior to HD sessions
Kopple et al, 2007, US [34] 40b/29 Int: 46.0 ± 2.7, con:  
41.3 ± 3.3a
Int: 9/6, con: 9/5
Leg press, leg extension,  
leg curl, calf extension up to  
3 × 6-8 reps, 80% of 5RM,  
3 × weekly for 18 wks
Muscle area: formula
FFM: DXA, bio impedance
Exercise prior to HD sessions
Song & Sohng, 2012, Korea [35] 44/40 Int: 52.1 ± 12.4, con: 
54.6 ± 10.1
Int: 8/12, con: 12/8
6 upper + 6 lower body  
exercises 3 × 10-15 reps, BORG 
11-15, 3 × weekly for 12 wks
Muscle mass, arm muscle  
circumference: bio impedance  
Muscle strength: dynamometer
QoL: questionnaire
Exercise prior to HD sessions
DePaul et al, 2002, Canada [36] 38/29 Int: 55 ± 16, con:  
54 ± 14
Int: 10/10, con: 13/4c
Knee flexion + knee extension 
up to 3 × 10 reps, 125% of  
baseline 5RM, 3 × weekly for  
12 wks
Muscle strength: 5RM
Physical function: 6MW
QoL: questionnaire
Exercise prior to or after HD 
sessions
Intra HD
Johansen et al, 2006, US [37] 40b/36 Int: 54.4 ± 13.6, con: 
56.8 ± 13.8
Int: 12/8, con: 14/6
5 lower body exercises 3 × 10 
reps, 60% of 3RM, 3 × weekly 
for 12 wks
LBM: DXA
Muscle area: MRI
Muscle strength: dynamometer + 
3RM
Physical function: stair climb, sit 
to stand, gait speed
QoL: questionnaire
The control group received a 
placebo product
Chen et al, 2010, US [38] 50/44 Int: 71.1 ± 12.6, con: 
66.9 ± 13.4
Int: 12/10, con: 11/11
5 lower body exercises 2 × 8 
reps, 60% of 1RM, 3 × weekly 
for 24 wks
LBM: DXA
Muscle strength: dynamometer
Physical function: battery
QoL: questionnaire
Pilot study, control group  
performed stretching
Cheema et al, 2007, Australia [39] 49/44 Int: 60.0 ± 15.3, con: 
65.0 ± 12.9
Int: 17/7, con: 17/8
10 upper + lower body  
exercises 2 × 8 reps, BORG  
15-17, 3 × weekly for 12 wks
Muscle area: CT scan
Muscle size: circumference
Muscle strength: dynamometer
Physical function: 6MW
QoL: questionnaire
Kirkman et al, 2014, UK [40] 23/19 Int: 48 ± 18, con:  
58 ± 15
Int: 7/2, con: 6/4
Leg press 3 × 8-10 reps, 80%  
of 1RM, 3 × weekly for 12 wks
Muscle area: MRI
Muscle strength: dynamometer
Physical function: 6MW, sit to 
stand
QoL: questionnaire
Control group performed 
stretching
6MW = Six-min. Walk Test; BORG = rating of perceived exertion; con = control; DXA = dual-energy X-ray absorptiometry; f = female; FFM = fat free mass; HD = haemodialysis; int = intervention; 
LBM = lean body mass; m = male; QoL = quality of life; reps = repetitions; RM = repetition maximum; SD = standard deviation.
a) Mean ± standard error of the mean.
b) From the 2-treatment arms strength training and control.
c) Gender reported for 17 participants.
3The Cochrane Collaboration’s tool for assessment of 
risk of bias: Random sequence generation; allocation 
concealment; blinding of participants and personnel; 
blinding of outcome assessment; incomplete outcome 
data; selective reporting; and other bias.
Meta-analyses had to be performed, if possible ac-
cording to the methods of the Cochrane Handbook 
[23] if there were comparable effect measures from 
more than one study and where measures of hetero-
gen eity indicated that pooling of results was appropri-
ate. The I2 statistics were used to describe heterogene-
ity among the included trials [24]. Data are presented 
as summary of findings, and the principles in the 
GRADE system [25] were used to assess the quality in 
the body of evidence associated with specific outcomes. 
The GRADE approach is based on the extent to which 
one can be confident that an estimate of effect or asso-
ciation reflects the item being assessed. The quality 
considers: within-study risk of bias (methodological 
quality); the directness of the evidence; heterogeneity 
of the data; precision of effect estimates; and risk of 
publication bias.
RESULTS
Through the electronic search (updated 31 October 
2017), a total of 6,927 hits were found. Once the 
search was limited to RCTs and supplied with results 
from hand searches, 214 references remained. After ex-
cluding duplicate reports, abstracts were screened, and 
15 references were obtained for full text assessment. 
Seven trials were excluded due to an insufficient exer-
cise programme description, insufficient results repor-
ting or an inadequate amount of strength training in 
the interventions [26-32]. Eight RCTs met the inclusion 
criteria [33-40]. In total, 290 participants undergoing 
HD were included (178 men and 112 women) and 
their mean ± standard deviation age ranged from 40.2 
± 13.5 to 71.1 ± 12.6 years (Table 1). The interven-
tion periods ranged from 12 weeks to six months. In 
one trial, the intervention and the control groups were 
supplied with an intradialytic oral high-protein nutri-
tion supplement [41]. In three trials, the control group 
performed range of motion exercises [36] or stretching 
[38, 40], interventions that the authors of this review 
found not to have the potential to significantly increase 
the tested parameters.
Whole muscle size was assessed using a formula 
[34], MRI [37, 40] or CT [39]. Five trials assessed mus-
cle mass using DXA [34, 37, 38, 41] or bio impedance 
techniques [34, 35]. Muscle strength was measured us-
ing 1-5RM tests [36, 37, 41], dynamometers [37-40] 
and an undefined equipment to measure leg press max-
imum strength [35]. Physical function was measured 
using the Six-minute Walk Test [36, 39, 40] or other 
tests [37, 38, 40]. QoL was measured using the SF36 
questionnaire [35-40] and the Kidney Disease 
Questionnaire [36]. None of the eight trials were 
judged as having a low risk of bias in all domains (see 
the assessments in Table 2).
Effects of interventions
See the main results in Table 3. Given the substantial 
differences in tests of the selected outcomes between 
the included studies, data syntheses were performed 
only in cases with reasonably clinical homogeneity.  
The overall results were described from the individual 
studies.
Muscle size or mass
Muscle mass was measured in seven trials and in-
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TABLE 2
Risk of bias assessment of the included studies.
Reference
Random sequence  
generation
Allocation  
concealment
Blinding of participants 
and personnel
Blinding of outcome  
assessment
Incomplete  
outcome data
Selective  
reporting
Inter HD
Dong et al, 2011, US [41] Low Unclear High High Low Low
Kopple et al, 2007, US [34] Low Unclear High High Low Low
Song & Sohng, 2012, Korea [35] Unclear Unclear High Higha Low Low
DePaul et al, 2002, Canada [36] Low Low High Low Low Low
Intra HD
Johansen et al, 2006, US [37] Low Low High High Low Low
Chen et al, 2010, US [38] Unclear Unclear High High Low Low
Cheema et al, 2007, Australia [39] Low Low High Lowb Low Low
Kirkman et al, 2014, UK [40] Low Low High Low Low Low
HD = haemodialysis.
a) The muscle strength tester was blinded.
b) The muscle size (primary outcome) tester was blinded.
4DANISH MEDICAL JOURNAL
 Dan Med J 66/1  January 2019
TABLE 3
Results of strength training on muscle mass, muscle strength, physical function and quality of life in the four included studies. Data are mean ± standard deviation 
(n) [p-value]. The all over quality of evidence was downgraded to very low by serious risk of bias, serious inconsistence between studies and serious imprecision.
Reference Muscle size
DXA scanning:  
LBM or FFM
Bio impedance:  
FFM, muscle mass or 
muscle circumference Muscle strength and PF QoL Authors’ conclusion
Inter HD
Dong et al, 
2011,  
US [41]
– LBM leg, kg
Int: 14.7 ± 7.0-14.6 ± 7.0 
(10)
Con: 17.4 ± 11.1-18. 2 ± 
12.8 (12)
[0.33]
– Leg press, lb
Int: 459 ± 370-582 ± 465 
(10)
Con: 475 ± 606-527 ± 
482 (12)
[0.12]
– No effect on muscle  
protein accretion
Kopple et al, 
2007,  
US [34]a
Proximal thigh, cm2
Int: 182.2 ± 44.5-179.7 ± 
49.6 (15)
Con: 183.1 ± 32.9-182.5 
± 37.0 (14)
[> 0.05]
Mid-thigh, cm2
Int: 144.0 ± 41.1-148.7 ± 
56.2 (15)
Con: 143.1 ± 28.1-144.5 
± 30.3 (14)
[> 0.05]
FFM leg, kg
Int: 14.03 ± 3.2-14.2 5 ± 
3.2 (13)
Con: 14.5 5 ± 3.4-14.72 ± 
3.4 (14)
[> 0.05]
FFM body, kg
Int: 53.0 ± 12.8-53.1 ± 
13.6 (15)
Con: 51.1 ± 12.0-51.7 ± 
12.0 (14)
[> 0.05]
No changes in body  
composition
Song & 
Sohng, 2012,  
Korea [35]
– – Muscle mass, kg
Int: 21.4 ± 3.6-22.2 ± 3.7 
(20)
Con: 22.8 ± 5.3-22.5 ± 5.2 
(20)
[0.002]
Arm circumference, cm
Int: 23.4 ± 1.4-23.5 ± 1.4 
(20) Con: 23.7 ± 2.7-23.8 
± 2.6 (20)
[0.747]
Leg muscle strength, kg
Int: 33.0 ± 15.3-37.3 ± 
19.0 (20); con: 34.8 ± 
20.3-33.4 ± 19.5 (20)
[0.027]
PCS, pts
Int: 64.5 ± 13.0-72.5 ± 
9.8 (20)
Con: 66.3 ± 1 2.5-64.2 ± 
12.2 (20)
[0.002]
MCS, pts
Int: 62.9 ± 15.9-69.4 ± 
13.7 (20)
Con: 62.7 ± 11.8-60.8 ± 
12.4 (20)
[0.014]
The strength training  
increased muscle mass, 
leg muscle strength, and 
QoL
DePaul et al, 
2002,  
Canada [36]
– – – Leg muscle strength, lbb
Int: 166 ± 94-228 ± 129 
(15)
Con: 171 ± 50-173 ± 46 
(14)
[0.02]
6MW, m
Int: 460 ± 136-464 ± 94 
(15)
Con: 426 ± 131-430 ± 80 
(14)
[0.52]
SF36, pts
Int: 100 ± 23-100 ± 21 
(15)
Con: 100 ± 18-96 ± 16 
(14)
[0.55]
KDQ, pts
Int: 49 ± 10-50 ± 14 (15)
Con: 52 ± 7-55 ± 7 (14)
[0.39]
Int resulted in an  
increased muscle 
strength, whereas PF  
and QoL remained 
unchanged
Intra HD
Johansen et 
al, 2006,  
US [37]
Quadriceps, cm2
Int: 47.9 ± 13.9-49.1 ± 
13.5 (19)
Con: 51.1 ± 10.9-47.6 ± 
11.0 (17)
[0.02]
LBM body, kg
Int: 47.5 ± 12.3-47.1 ± 
11.2 (19)
Con: 48.4 ± 8.2-48.2 ± 8.8 
(17)
[0.66]
Isometric knee extension 
90°/s, Nmc
Int: 39.2 ± 25.1-46.8 ± 
28.9 (19); con: 41.7 ± 
19.4-43.3 ± 22.8 (17)
[0.77]
Knee extension 3RM, kgd
Int: 14.0 ± 8.4-22.6 ± 
11.6 (19); con: 19.2 ± 
8.7-20.0 ± 9.1 (17)
[< 0.0001]
Sit-to-stand, se
Int: 18.0 ± 11.4-15.1 ± 
7.4 (19); con: 15.2 ± 3.8-
15.1 ± 5.1 (17)
[0.30]
PF, pts
Int: 46 ± 12-54 ± 12 (22)
Con: 52 ± 11-50 ± 11 (22)
[0.02]
Resistance exercise  
training increased  
muscle size
CONTINUES 
5creased in three trails using different outcome meas-
ures [35, 38, 40]. The same parameters remained 
unchanged in different tests in two other trails [33, 
34]. In each of the remaining two trials, two methods 
to investigate the effects on muscle mass were used and 
the trials found positive as well as negative effects [37, 
39]. The data for two trails’ tests of the mid-thigh mus-
cle area were pooled and showed no effect in favour of 
DANISH MEDICAL JOURNAL
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TABLE 3 CONTINUED
Reference Muscle size
DXA scanning:  
LBM or FFM
Bio impedance:  
FFM, muscle mass or 
muscle circumference Muscle strength and PF QoL Authors’ conclusion
Intra HD
Chen et al, 
2010,  
US [38]
– LBM leg, kg
Int: 6.9 ± 1.7-7.2 ± 2.0 
(21)
Con: 7.2 ± 1.8-6.9 ± 1.7 
(21)
[0.0001]
LBM body, kg
Int: 45.8 ± 8.9-47.9 ± 9.9 
(21)
Con: 47.8 ± 9.0-46.3 ± 8.7 
(21)
[0.0001]
– Physical performance, 
batteryf
Int: 5.0 (5.2)-7.0 (7.2) 
(22)
Con: 6.0 (7.0)-6.5 (4.5) 
(22)
[0.03]
Knee extension, kg
Int: 11.4 ± 5.0-15.8 ± 5.0 
(21)
Con: 14.8 ± 6.0-12.1 ± 6.1 
(21)
[0.0001]
PCS, pts
Int: 64.5 ± 13.0-72.5 ± 
9.8 (20)
Con: 66.3 ± 12. -64.2 ± 
12.2 (20)
[0.002]
MCS, pts
Int: 37 ± 11-37 ± 9 (22)
Con: 39 ± 11-38 ± 9 (22)
[0.6]
Strength training  
improved physical  
performance
Cheema et al, 
2007,  
Australia [39]
Mid-thigh, cm2
Int: 104.2 ± 25.6-104.2 ± 
25.6 (24)
Con: 98.9 ± 21.5-97.4 ± 
21.9 (25)
[0.4]
– Mid-thigh circumference, 
cmg
Int: 47.5 ± 6.0-47.6 ± 5.8 
(24)
Con: 47.8 ± 5.9-48.2 ± 3.8 
(25) 
[0.04]
Muscle strength, kgb
Int: 98.1 ± 36.6-109.5 ± 
35.1 (24)
Con: 86.0 ± 33.8-85.2 ± 
34.3 (25)
[0.002]
6MW, m
Int: 497 ± 133-515 ± 155 
(24)
Con: 406 ± 123-414 ± 
127 (25)
[0.16]
PF, pts
Int: 74 ± 26-81 ± 22 (24)
Con: 64 ± 22-64 ± 25 (25)
[0.02]
VT, pts
Int: 58 ± 22-61 ± 22 (24) 
Con: 56 ± 24-49 ± 28 (25)
[0.02]
Progressive resistance 
training resulted in  
improved body  
composition
Kirkman et al, 
2014,  
–UK [40]
Thigh, cm2
Int: 2,822 ± 438-2,906 ± 
489 (9)
Con: 2,490 ± 601-2,380 ± 
643 (10)
[0.007]
– – Knee extension, N
Int: 179 ± 109-287 ± 86 
(9)
Con: 151 ± 79-201 ± 77 
(10)
[0.012]
6MW, m
Int: 532 ± 95-571 ± 101 
(9)
Con: 460 ± 162-520 ± 
160 (10)
[0.4]
Sit-to-stand, sh
Int: 11 ± 2-13 ± 3 (9)
Con: 10 ± 4-11 ± 5 (10)
[0.2]
SF36, pts
Data not shown,  
not significant
Progressive resistance 
training was safe and  
increased muscle volume 
and strength
6MW = Six-min. Walk Test; con = control; FFM = fat free mass; HD = haemodialysis; int = intervention; KDQ = Kidney Disease Questionnaire; LBM = lean body mass; MCS = Mental Component 
Scale; PCS = Physical Component Scale; PF = physical function; QoL = quality of life; RM = repetition maximum; SF36 = Short Form 36; VT = vitality.
a) Data are concerted from mean ± standard error of the mean to mean ± standard deviation. 
b) Combined measure of more tests.
c) Similar results in the 120°/s tests.
d) Similar results in hip abduction and hip flexion tests.
e) Similar results in gait speed and stairs tests.
f) Median (interquartile range). 
g) Similar results in the mid-arm circumference tests.
h) Similar results in 8-feet up and go test.
6strength training [34, 39] (mean difference (95% con-
fidence interval) 1.81 (–15.33-18.95), p = 0.84, I2 = 
0). Two studies’ data for leg lean body mass [33, 38] 
and two studies for lean body mass [37, 38] were also 
pooled without yielding any significant difference be-
tween groups (0.57 (–0.96-2.10), p = 0.46, I2 = 0, and 
2.05 (–3.96-8.05), p = 0.50, I2 = 0), respectively). As 
presented in Table 3 there were more studies reporting 
on the primary outcome. However, because of incom-
parable methods and clinical heterogeneity, these trials 
could not be included in the meta-analysis. The results 
of the remaining trials did not show significant differ-
ences between the intervention and control groups.
Muscle strength
Muscle strength was measured in eight tests in seven 
studies. In five trials, muscle strength increased [35, 
36, 38-40], and in one trial it remained unchanged 
[41]. In the sixth trail, muscle strength was increased 
when it was assessed using a 3RM test, whereas it re-
mained unchanged when it was assessed using a dyna-
mometer [37].
Objectively tested physical function
Physical function increased in a study that used a test 
battery [38], and it remained unchanged in three  
studies using the Six-minute Walk Test [36, 39, 40], 
and in two studies using the 30-Second Sit-to-Stand 
Test [37, 40]. This was also true when the data were 
pooled for the Six-minute Walk Test (7 (–52-67), p = 
0.81, I2 = 0) and the 30-Second Sit-to-Stand Test (–0.2 
(–4.0-3.6), p = 0.92, I2 = 0) [37, 40].
Quality of life
The SF36 scales Physical Component Scale [35, 38], 
Physical Function [37, 39] and Vitality [39] increased 
after strength training in four studies. In two studies, 
the Mental Component Scale [35, 38] and overall QoL 
scores [36] remained unchanged. Pooled data for the 
Physical Component Scale [35, 38] showed positive ef-
fects (Figure 1), and this was also true for pooled data 
for Physical Function [37, 39] (9.38 (0.79-18.0), p = 
0.03, I2 = 0). Pooled data for the Mental Component 
Scale showed no effects of strength training [35, 38] 
(3.47 (–3.39-17.97)). Finally, one study did not report 
data for the unchanged SF36 scale scores [40].
Adverse effects
In the trial by DePaul [36], five patients from the 
strength training group dropped out of the study due to 
reasons that could be results of the strength training in-
tervention (fatiguing, sore legs, hypotension, a wound, 
and muscle pain). In the trial by Kirkman [40], no pa-
tients dropped out due to adverse effects associated 
with strength training, even though cramps, delayed 
onset muscle soreness, hypotension and a wound on 
the back were reported by participants in the strength 
training group.
Due to the small number and heterogeneous  
studies, it was not possible to undertake any of the 
planned subgroup or sensitivity analyses described in 
the protocol, including measuring differences between 
effects of inter- and intradialytic interventions. The 
GRADE Working Group grades of evidence [24] were 
categorised as being of “Very low quality” for all evalu-
ated outcomes. The quality of evidence was down-
graded because of imprecision (few studies, few parti-
cipants); heterogeneity and a high or uncertain risk of 
bias. However, there was only a moderate to small de-
gree of indirectness (limited use of surrogate out-
comes/quality measurements) in the included trials.
DISCUSSION
The main finding of this study was inconsistent results 
of strength training on muscle mass in patients under-
going HD. While the results of the trials indicated pos-
itive effects on muscle strength, there were effects of 
strength training on self-reported physical function and 
physical health.
As only half of the tests of muscle mass found effects 
of strength training, it may be difficult to achieve mus-
cle hypertrophy with strength training in patients  
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FIGURE 1
Forest plot comparing the Physical Component Scale from the Short Form 36 questionnaire.
Experimental control Mean difference
Study or subgroup Mean SD Total Mean SD Total Weight IV, fixed (95% CI)
Chen et al, 2010 [38] 8 17 22 –2 15.6 22 54.2% 10.00 (0.36-19.64)
Song & Sohng, 2012 [35] 8 16.3 20 –2.1 17.5 22 45.8% 10.10 (–0.38-20.58)
Total (95% CI) 42 42 100.0% 10.05 (2.95-17.14)
Heterogeneity: chi2  = 0.00, df = 1 (p = 0.99); I2 = 0%
Test for overall effect: Z = 2.77 (p = 0.0006)
CI = confidence interval; IV = inverse variance.
Mean difference 
IV, fixed, 95% CI
Favours (control)     Favours (experimental)
– 100                – 50                     0                      50                   100
7undergoing HD. However, the variation between the 
trials in terms of age and gender distribution, tests 
used, and interventions made makes it difficult to draw 
any final conclusions. The inconsistent results of the  
interventions on muscle mass may also be related to 
relatively low training intensities. Furthermore, regard-
ing tests of muscle mass and size, the analyses of mus-
cle fibre sizes in cross sectional cuts of muscle biopsies 
has been recognised as more adequate methods for as-
sessing muscle hypertrophy [16]. However, none of the 
included studies obtained muscle biopsies to investi-
gate the muscle size before and after training, and the 
methods used may not be adequate for the detection 
muscle hypertrophy. An excluded trial investigated the 
effect of interdialytic strength training on muscle fibre 
cross sectional area analysed in cross sectional cuts of 
muscle biopsies [42]. After five months of progressive 
strength training thrice weekly, only a modest increase 
in type 2X fibres was found [43].
If muscle hypertrophy is difficult to achieve in pa-
tients undergoing HD, the question remains which 
compromising factors have the most significant coun-
teracting effect on muscle growth. The anticipated hy-
pertrophy related to strength training may have been 
suppressed by the disturbance of the patients’ protein 
balance, as mentioned in the Introduction. In general, 
dialysis populations are relatively old, and in the at-
tempt to increase muscle mass with strength training, 
increasing age is a limiting factor due to an age-related 
reduced protein synthesis rate [44]. However, in most 
of the trials, the patient samples in the studies included 
in this review had younger mean ages than in general 
dialysis populations, and age may therefore not be the 
primary limiting factor. Regarding the lack of evidence-
based muscle hypertrophy in this review, it should be 
noted that all the included interventions used exercise 
sessions performed prior to or during HD sessions. If 
the exercises were performed in a fasting state and pa-
tients were not followed by an ingestion of proteins 
during the HD treatment, an additive protein break-
down may have occurred as a result of the strength 
training and the following catabolism related to HD.  
In the study by Dong et al, strength training was com-
bined with an oral energy/protein supplement [41]. 
The strength training was, however, not associated 
with any additive positive effects on lean body mass. 
On the other hand, unchanged muscle mass could be a 
result of a relatively low training dose with only three 
sets of one exercise and only moderate progression dur-
ing the intervention period.
Muscle strength increased in six of eight tests in the 
included trials, and this indicates an effect of strength 
training on muscle strength in patients undergoing HD 
[35-40]. It is, however, important to note that the tests 
used could have varying validity. In the trail by Johan-
sen et al [37], muscle strength was measured using a 
dynamometer and a 3RM test. It may be easier to in-
crease the results of RM tests, as the participants in 
such trials are tested with the equipment that they use 
in the exercises and with which they thereby become 
very familiarised. Indeed, in the trial with the two men-
tioned tests, there was an effect on muscle strength 
when it was measured using the 3RM test, but not with 
the dynamometer test.
An increase in muscle strength after a period of 
strength training may be the result of muscle hyper-
trophy and/or an improved neuromuscular function. 
Indeed, in the studies by Song & Sohng [35], Chen et al 
[38] and Kirkman et al [40] there were positive effects 
on muscle strength and muscle mass in parallel, sug-
gesting an association. Likewise, in the trial by Dong et 
al there were no effects on either muscle strength or 
muscle mass [33]. However, positive effects of strength 
training on muscle strength may also occur as a result 
of improved neuromuscular functions [45]. In a study 
on patients undergoing HD that was not included in 
this review, increased muscle strength was, indeed, as-
sociated with a positive effect on the neuromuscular 
function assessed using surface electromyography 
[46]. In addition, only a modest muscle hypertrophy 
was achieved in the mentioned study, suggesting that 
an improved neuromuscular function is the primary 
driver in generating the effects of strength training in 
patients with several catabolic factors undergoing HD, 
as described above.
The most pronounced effects of strength training 
were reported on self-reported physical function and 
the Physical Component Scale from the SF36. The pos-
itive effects on QoL parameters have been presented in 
a previous study [47]. Whereas objectively tested mus-
cle mass and muscle strength are important physio-
logical outcomes, patient-reported outcomes may be of 
great importance in relation to motivation and adher-
ence to exercise training interventions.
In this review inter- and intradialytic interventions 
were included. It may be hypothesised that exercise 
training during the HD treatment was an unfavourable 
situation for exercise with higher loads, and thereby as-
sociated with a reduced effect on muscle growth [16]. 
It was, however, not possible to discern any difference 
in the effects of the intra- and interdialytic strength 
training, and the two exercise regimes may thus have 
the same potential effects.
An important aspect of this review was that the in-
vestigated seriously ill patient population was able to 
conduct relatively rigorous strength training. Only one 
study found that adverse effects were related to the  
intervention [36]. However, only one drop-out was re-
lated to a wound, which may be a critical and concern-
ing point. The risk of developing a wound emphasises 
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8the need for a careful approach when patients undergo-
ing dialysis perform strength training, especially pa-
tients with diabetes and its complications. In addition, 
other training modalities should also be considered. 
Hence, previous studies have reported positive effects 
on other outcomes, among them aerobic capacity [18].
Based on the results of this review, strength training 
should be recommended as one of more training mo-
dalities to patients undergoing dialysis. The interven-
tion can be used during or not concurrently with HD. 
Leg exercises should be prioritised as strong legs may 
have most significant effect on physical function. 
Furthermore, the legs hold the largest muscles and ex-
ercising them may therefore have the most pronounced 
metabolic effect. Good results should be possible to 
achieve with 30 min training thrice weekly. The effects 
may be achieved with different intensities, but the RM 
should not exceed 15 in order to define the interven-
tion as strength training.
A future multicentre RCT would be welcome to fur-
ther investigate these issues. The effects could be tested 
on hard end-points, among them death, after an inter-
vention in the very early phase after HD is initialised. 
Another additional aim may be to compare effects of 
strength training performed during and not concur-
rently with HD. Whilst exercises that are not performed 
concurrently with HD may be possible to perform with 
higher loads than during HD, the later may be associ-
ated with a counteracting effect on the HD-induced 
protein catabolism.
The methods used in the individual trials were of 
various quality. However, because of a limited use of 
surrogate outcomes, we conclude that there was a me-
dium-to-low degree of indirectness. None of the in-
cluded trials were categorised as having a low risk of 
bias in all domains, as it was inherent in the study de-
sign that it was not possible to blind the patients under-
going strength training or those who were not. Fur-
thermore, five of the trials did not blind the outcome 
assessment, and all over more types of potential bias 
were judged as “unknown”. Thus, the quality of evi-
dence was downgraded as a result of a serious risks of 
bias. The number of trials and also the number of par-
ticipants were relatively low, which resulted in a high 
degree of imprecision in the assessment. In conclusion, 
the overall quality of the body of evidence for all the 
outcomes was judged as being very low.
CONCLUSIONS
The data did not demonstrate evidence that strength 
training is an effective intervention to increase the 
amount of protein stored as muscle mass in patients 
undergoing HD. The effect of strength training on mus-
cle strength was positive. The most positive effects of 
the interventions were found on self-reported physical 
function and the Physical Component Scale from the 
SF36 questionnaire. Few adverse effects were reported 
and patients undergoing dialysis should not be advised 
against strength training.
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